Oral ezatiostat HCl (Telintra<sup>®</sup>, TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor
<p>Abstract</p> <p>Idiopathic chronic neutropenia (ICN) describes a heterogeneous group of hematologic diseases characterized by low circulating neutrophil levels often associated with recurrent fevers, chronic mucosal inflammation, and severe systemic infections. The severity and...
Main Authors: | Lyons Roger M, Wilks Sharon T, Young Shelby, Brown Gail L |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://www.jhoonline.org/content/4/1/43 |
Similar Items
-
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra<sup>®</sup>, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
by: Burris Howard, et al.
Published: (2009-05-01) -
Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
by: Raza Azra, et al.
Published: (2012-04-01) -
Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: A case report of sustained hematologic response following an abbreviated exposure
by: Quddus Fahd, et al.
Published: (2010-04-01) -
Deactivation of the JNK Pathway by GSTP1 Is Essential to Maintain Sperm Functionality
by: Marc Llavanera, et al.
Published: (2021-02-01) -
Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome
by: Galili, Naomi, et al.
Published: (2012)